Muscular Dystrophy and Disability Benefits

Muscular dystrophy includes several genetic disorders that cause muscle weakness, with different patterns and courses. A benefits application should identify the diagnosed type and present limitations rather than assuming every form progresses in the same way. Muscle, breathing or heart findings may all be relevant when documented.

Listing 11.13 Is an Entry Point

SSA’s adult listing 11.13 addresses muscular dystrophy. It includes specified severe motor limitations or combined physical and mental limitations. The listing and neurological definitions must be considered together; a genetic result alone is not the complete functional test.

Other affected body systems may also require evaluation. If no listing is met or medically equaled, SSA assesses residual functional capacity and the combined effects of the person’s impairments. Describe present abilities and the expected course, not an assumed future stage.

Identify the Type and Current Findings

• Provide information about the diagnostic workup, including genetic, muscle-enzyme, nerve or muscle testing already performed.
• Include current strength, walking, transfer and upper-limb assessments.
• Identify relevant heart or breathing evaluations and treatment when those systems are affected.
• Record equipment, personal assistance and the tasks that remain difficult despite support.

Tests serve different purposes. A report establishing a subtype does not necessarily describe how long someone can stand or how much assistance a transfer requires. Ask the treating team to explain clinical findings and practical limitations without ordering a test solely for a website checklist.

Care Is Individualized

Management may include physical or occupational therapy, respiratory support, speech-related care, assistive devices, medicines and selected surgery. The combination depends on the type and individual needs. This guide does not claim that a particular drug is suitable for every muscular dystrophy subtype or that treatment cures the condition.

Keep the care plan and reports of response, including actual side effects and remaining weakness. Describe time needed for treatment and help with equipment or everyday activities. Explain delays in specialist care, device delivery or other services with dates and the efforts made to obtain them.

A gap in care needs an explanation, including cost, unavailable appointments or adverse effects. SSA’s failure-to-follow-prescribed-treatment rule applies only in defined circumstances: the person would otherwise qualify, their own medical source prescribed treatment, and they did not follow it. SSA then considers whether it would restore the ability to perform substantial gainful activity and whether there was good cause. A missed visit alone does not answer those questions.

Translate Weakness Into Work Demands

Describe standing, walking, reaching, carrying, hand use and the ability to repeat tasks. For a hypothetical example, a person may reach a shelf once but be unable to repeat overhead activity at the pace a job requires. Record actual duration and support rather than assuming that a single successful movement proves endurance.

Include reduced duties, assistance or schedule changes tried at work. Before an appeal, check that SSA received current specialist and rehabilitation records, along with evidence about any affected heart or respiratory function. Use the decision’s appeal instructions promptly.

Does a Genetic Diagnosis Automatically Establish Benefits?

It can be important diagnostic evidence, but SSA still evaluates the applicable medical criteria and nonmedical eligibility. The record should identify the subtype, current function and relevant associated impairments.

Applications and Approval Data

This guide concerns adult claims. SSA generally requires a medically established impairment that prevents substantial gainful activity for at least 12 continuous months, is expected to do so, or is expected to result in death. SSDI also has insured-work requirements; SSI has financial and other eligibility rules. Childhood disability rules differ.

A rate drawn from one muscular dystrophy subtype, age group or clinical study cannot be presented as a universal benefits approval rate. This guide assigns no personal percentage. See how disability approval statistics are defined.

Use our application guide and medical and work records checklist. If denied, read the notice and its review instructions promptly; our appeals guide explains the process.

Related Reading

How Inherited Neuropathy Evidence Differs, or return to the condition directory.

Sources and References

• Muscular Dystrophy | MD | MedlinePlus
• 11.00 Neurological – Adult | Disability | SSA^[1]
• Code of Federal Regulations § 404.1545^[2]
• Part II – Evidentiary Requirements | Disability | SSA^[3]
• SSR 18-3p^[4]
• Appeal a decision we made | SSA^[5]
• Part I – General Information | Disability | SSA^[6]
• Code of Federal Regulations § 404.1520^[7]

General educational information, not individualized medical or legal advice. Treatment decisions belong with your healthcare professional. Disability Benefit Guide USA is not affiliated with the Social Security Administration. Read how our guides are prepared.

Official Sources and References

These SSA.gov links support the explanations above. Official applications, account services, and agency forms are completed through SSA.

1. 11.00 Neurological – Adult | Disability | SSA — SSA.gov
2. Code of Federal Regulations § 404.1545 — SSA.gov
3. Part II – Evidentiary Requirements | Disability | SSA — SSA.gov
4. SSR 18-3p — SSA.gov
5. Appeal a decision we made | SSA — SSA.gov
6. Part I – General Information | Disability | SSA — SSA.gov
7. Code of Federal Regulations § 404.1520 — SSA.gov